理邦仪器收盘上涨1.17%，滚动市盈率44.85倍，总市值70.14亿元

Group 1 - Company shares closed at 12.1 yuan, up 1.17%, with a rolling PE ratio of 44.85 times and a total market capitalization of 7.014 billion yuan [1] - The average PE ratio for the medical device industry is 44.91 times, with a median of 31.89 times, placing the company at the 87th position in the industry ranking [1] - As of February 20, 2025, the number of shareholders increased to 32,134, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - For the third quarter of 2024, the company reported revenue of 1.382 billion yuan, a year-on-year decrease of 9.29%, and a net profit of 172 million yuan, down 27.41% [2] - The company's sales gross margin stands at 58.17% [2] - The company specializes in the research, development, production, sales, and service of medical electronic devices and in vitro diagnostic products, including patient monitoring, electrocardiogram diagnostics, maternal and child health, ultrasound imaging, and smart healthcare [1]